AAAAAA

   
Results: 1-11 |
Results: 11
PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
Authors: PAGANI O ONEILL A CASTIGLIONE M GELBER RD GOLDHIRSCH A RUDENSTAM CM LINDTNER J COLLINS J CRIVELLARI D COATES A CAVALLI F THURLIMANN B SIMONCINI E FEY M PRICE K SENN HJ
Citation: O. Pagani et al., PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI, European journal of cancer, 34(5), 1998, pp. 632-640
THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE
Authors: PINDER SE MURRAY S ELLIS IO TRIHIA H ELSTON CW GELBER RD GOLDHIRSCH A LINDTNER J CORTESFUNES H SIMONCINI E BYRNE MJ GOLOUH R RUDENSTAM CM CASTIGLIONEGERTSCH M
Citation: Se. Pinder et al., THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE, European journal of cancer, 34, 1998, pp. 513-513
PHASE-II STUDY OF VINORELBINE (VNB) AND 5 DAYS CONTINUOUS-INFUSION OFIFOSFAMIDE (IFO) IN PRETREATED PATIENTS (PTS) WITH ADVANCED BREAST-CANCER (ABC) - PRELIMINARY-RESULTS
Authors: FERRARI VD SIMONCINI E MARPICATI P MONTINI E RANGONI G GROTTOLO A MARINI G
Citation: Vd. Ferrari et al., PHASE-II STUDY OF VINORELBINE (VNB) AND 5 DAYS CONTINUOUS-INFUSION OFIFOSFAMIDE (IFO) IN PRETREATED PATIENTS (PTS) WITH ADVANCED BREAST-CANCER (ABC) - PRELIMINARY-RESULTS, Annals of oncology, 9, 1998, pp. 138-138
THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY
Authors: PINDER SE MURRAY S ELLIS IO TRIHIA H ELSTON GW GELBER RD GOLDHIRSCH A LINDTNER J CORTESFUNES H SIMONCINI E BYRNE MJ GOLOUH R RUDENSTAM CM CASTIGLIONEGERTSCH M GUSTERSON BA
Citation: Se. Pinder et al., THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY, Cancer, 83(8), 1998, pp. 1529-1539
MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
Authors: GOLDHIRSCH A GELBER RD CASTIGLIONE M ONEILL A THURLIMANN B RUDENSTAM CM LINDTNER J COLLINS J FORBES J CRIVELLARI D COATES A CAVALLI F SIMONCINI E FEY MF PAGANI O PRICE K SENN HJ
Citation: A. Goldhirsch et al., MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI, Annals of oncology, 8(8), 1997, pp. 751-756
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER
Authors: HURNY C BERNHARD J COATES AS CASTIGLIONEGERTSCH M PETERSON HF GELBER RD FORBES JF RUDENSTAM CM SIMONCINI E CRIVELLARI D GOLDHIRSCH A SENN HJ
Citation: C. Hurny et al., IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER, Lancet, 347(9011), 1996, pp. 1279-1284
ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER
Authors: CRIVELLARI D PRICE KN HAGEN M GOLDHIRSCH A GELBER RD CASTIGLIONE M COATES AS RUDENSTAM CM COLLINS J LINDTNER J CORTESFUNES H GUDGEON A SIMONCINI E BYRNE M SCHNURCH HG FEY M TATTERSALL MHN FORBES JF CAVALLI F SENN HJ
Citation: D. Crivellari et al., ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER, Annals of oncology, 6(8), 1995, pp. 769-776
MITOMYCIN-C AND LONIDAMINE AS 2ND-LINE THERAPY FOR COLORECTAL-CANCER - A PHASE-II STUDY
Authors: ZANIBONI A MERIGGI F ALGHISI A MUTTI S DISTEFANO L RIZZI A BETTINI L SIMONCINI E MARPICATI P MONTINI E MARINI G
Citation: A. Zaniboni et al., MITOMYCIN-C AND LONIDAMINE AS 2ND-LINE THERAPY FOR COLORECTAL-CANCER - A PHASE-II STUDY, Tumori, 81(6), 1995, pp. 435-437
MICE - A NEW ACTIVE COMBINATION FOR NONSMALL CELL LUNG-CANCER
Authors: ARCANGELI G ZANIBONI A MILANO S MERIGGI F SIMONCINI E MARPICATI P MARINI G
Citation: G. Arcangeli et al., MICE - A NEW ACTIVE COMBINATION FOR NONSMALL CELL LUNG-CANCER, European journal of cancer, 29A(13), 1993, pp. 1848-1850
L-FOLINIC ACID AND 5-FLUOROURACIL IN THE TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II STUDY
Authors: ZANIBONI A MERIGGI F ARCANGELI G MARPICATI P MONTINI E SIMONCINI E MARINI G
Citation: A. Zaniboni et al., L-FOLINIC ACID AND 5-FLUOROURACIL IN THE TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II STUDY, Annals of oncology, 4, 1993, pp. 190000041-190000043
Risultati: 1-11 |